These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 16980074

  • 1. Rituximab therapy for mixed cryoglobulinemia in seven renal transplant patients.
    Basse G, Ribes D, Kamar N, Mehrenberger M, Sallusto F, Esposito L, Guitard J, Lavayssière L, Oksman F, Durand D, Rostaing L.
    Transplant Proc; 2006 Sep; 38(7):2308-10. PubMed ID: 16980074
    [Abstract] [Full Text] [Related]

  • 2. Rituximab therapy for de novo mixed cryoglobulinemia in renal transplant patients.
    Basse G, Ribes D, Kamar N, Mehrenberger M, Esposito L, Guitard J, Lavayssière L, Oksman F, Durand D, Rostaing L.
    Transplantation; 2005 Dec 15; 80(11):1560-4. PubMed ID: 16371926
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis.
    Roccatello D, Baldovino S, Rossi D, Mansouri M, Naretto C, Gennaro M, Cavallo R, Alpa M, Costanzo P, Giachino O, Mazzucco G, Sena LM.
    Nephrol Dial Transplant; 2004 Dec 15; 19(12):3054-61. PubMed ID: 15494358
    [Abstract] [Full Text] [Related]

  • 5. Rituximab may form a complex with IgMkappa mixed cryoglobulin and induce severe systemic reactions in patients with hepatitis C virus-induced vasculitis.
    Sène D, Ghillani-Dalbin P, Amoura Z, Musset L, Cacoub P.
    Arthritis Rheum; 2009 Dec 15; 60(12):3848-55. PubMed ID: 19950292
    [Abstract] [Full Text] [Related]

  • 6. Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia: efficacy and safety in the absence of steroids.
    Quartuccio L, Soardo G, Romano G, Zaja F, Scott CA, De Marchi G, Fabris M, Ferraccioli G, De Vita S.
    Rheumatology (Oxford); 2006 Jul 15; 45(7):842-6. PubMed ID: 16418196
    [Abstract] [Full Text] [Related]

  • 7. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK, Bansal SB, Gupta A, Gulati S, Kumar A, Prasad N.
    Clin Transplant; 2006 Jul 15; 20(6):677-83. PubMed ID: 17100715
    [Abstract] [Full Text] [Related]

  • 8. Early recurrence of nephrotic syndrome (immunoglobulin m nephropathy) after renal transplantation successfully treated with combinations of plasma exchanges, immunoglobulin, and rituximab.
    Westphal S, Hansson S, Mjörnstedt L, Mölne J, Swerkersson S, Friman S.
    Transplant Proc; 2006 Oct 15; 38(8):2659-60. PubMed ID: 17098031
    [Abstract] [Full Text] [Related]

  • 9. [Membranoproliferative glomerulonephritis in patients with cryoglobulinemia complicating hepatitis C virus: report of 11 cases].
    Ben Fatma L, Ben Hamida F, Aoudia R, Goucha R, Kaaroud H, Béji S, Barbouch S, Hedri H, Abderrahim E, Elyounsi F, Ben Abdallah T, Ben Moussa F, Kheder A.
    Tunis Med; 2007 Mar 15; 85(3):220-4. PubMed ID: 17668578
    [Abstract] [Full Text] [Related]

  • 10. Rituximab induces regression of hepatitis C virus-related membranoproliferative glomerulonephritis in a renal allograft.
    Bestard O, Cruzado JM, Ercilla G, Gomà M, Torras J, Serón D, Rama I, Ibernon M, Viñas O, Carrera M, Grinyó JM.
    Nephrol Dial Transplant; 2006 Aug 15; 21(8):2320-4. PubMed ID: 16751656
    [No Abstract] [Full Text] [Related]

  • 11. [Treatment of HCV-associated cryoglobulinemic glomerulonephritis].
    Laurino S, Borrelli S, Catapano F, Mascia S, D'Angio' P, Calabria M, Grimaldi M, Salvio A, Minutolo R, De Nicola L, Conte G.
    G Ital Nefrol; 2009 Aug 15; 26(3):318-27. PubMed ID: 19554529
    [Abstract] [Full Text] [Related]

  • 12. Experiences and problems pre-operative anti-CD20 monoclonal antibody infusion therapy with splenectomy and plasma exchange for ABO-incompatible living-donor liver transplantation.
    Usui M, Isaji S, Mizuno S, Sakurai H, Uemoto S.
    Clin Transplant; 2007 Aug 15; 21(1):24-31. PubMed ID: 17302588
    [Abstract] [Full Text] [Related]

  • 13. Anti-CD20 monoclonal antibody (rituximab) for the treatment of membranous nephropathy after living-unrelated kidney transplantation: a case report.
    Sirimongkolrat T, Premasathian N, Vongwiwatana A, Limsrichamrern S, Cheunsuchon B, Vasuvattakul S.
    Transplant Proc; 2008 Sep 15; 40(7):2440-1. PubMed ID: 18790261
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Treatment of symptomatic transplant glomerulopathy with rituximab.
    Rostaing L, Guilbeau-Frugier C, Fort M, Mekhlati L, Kamar N.
    Transpl Int; 2009 Sep 15; 22(9):906-13. PubMed ID: 19453996
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.